Author

P. N. Monk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

L. J. Partridge· 2 shared L. R. Green· 2 shared L. Urwin· 2 shared B. Ciani· 1 shared B. Veeraraghavan· 1 shared C. E. Turner· 1 shared D. C. James· 1 shared D. Murugan· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

L. J. Partridge

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway

L. R. Green, R. Issa, F. Albaldi, L. Urwin, H. Khalid, C. E. Turner, B. Ciani, L. J. Partridge, P. N. Monk

This study shows CD9 and syndecan-1 cooperate for staphylococcal adhesion, with fibronectin also playing a role, and suggests CD9-targeted therapies could block bacterial entry.

bioRxiv · Jan 17, 2023Microbiology

Re-sensitising XDR biofilms using a combination of bacteriophage cocktails and colistin: a natural approach

N. K. Devanga Ragupathi, D. P. Muthuirulandi Sethuvel, M. Gopikrishnan, D. Murugan, R. Juliet, M. Majhi, M. Murugesan, G. P. D. C, L. Wannigama, P. N. Monk, E. Karunakaran, B. Veeraraghavan

This study explores using bacteriophage cocktails combined with colistin to combat XDR bacterial biofilms, showing significant reduction in minimum biofilm eradication concentrations.

bioRxiv · Feb 4, 2022 · PreprintMicrobiology

ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin

L. J. Partridge, L. Urwin, M. J. Nicklin, D. C. James, L. R. Green, P. N. Monk

This paper shows that SARS-CoV-2 spike protein can interact with human cells without ACE2 and that unfractionated heparin inhibits this interaction.

Cells · Jun 7, 2021Peer-reviewedMicrobiology